Counting the Cost of Corrections in Clinical Trials Labelling

Feb 13, 2017

Peter Muller, Managing Director, Schlafender Hase, Americas, says “Bringing a new drug to market costs millions, so it’s highly risky to leave product labelling and packaging to chance. Especially if it’s expensive professionals giving hours of their time to these ...

Read More